Media
Company news
ChemDiv Extends CMC Services
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
Pop-Science
Novel Potent TIM-3 Inhibitors were discovered in ChemDiv’s collection.
The ChemDiv’s proprietary library of chemically diverse small molecule compounds was demonstrated to be a source of selective inhibitors targeting specific check points was found out in a recen...
Science & Nature Digest
Science & Nature Reviews, February 2022. Part II
Neurophysiology
Kelava, I., Chiaradia, I., Pellegrini, L. et al. Androgens increase excitatory neurogenic potential in human brain organoids. Nature 602, 112–116 (2022)
Sex-based brain dif...
Pharma News
CorriXR Therapeutics
CorriXR Therapeutics Announces Publication of Preclinical Data Demonstrating Potential of CRISPR-Directed Gene Editing to Overcome Drug Resistance in Solid Tumors